Allakos Inc. (ALLK)
May 15, 2025 - ALLK was delisted (reason: acquired by Concentra Biosciences)
0.3291
-0.0002 (-0.06%)
Inactive · Last trade price on May 14, 2025

Company Description

Allakos Inc., a clinical stage biotechnology company, engages in the development of therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States.

The company was incorporated in 2012 and is headquartered in San Carlos, California.

Allakos Inc.
Allakos logo
CountryUnited States
Founded2012
IPO DateJul 19, 2018
IndustryBiotechnology
SectorHealthcare
Employees131
CEORobert Alexander

Contact Details

Address:
825 Industrial Road, Suite 500
San Carlos, California 94070
United States
Phone650 597 5002
Websiteallakos.com

Stock Details

Ticker SymbolALLK
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001564824
CUSIP Number01671P100
ISIN NumberUS01671P1003
Employer ID45-4798831
SIC Code2834